iiinova — where your digital self keeps evolving

Toronto Cannabis and Cannabinoid Research Consortium @tc3consortium.bsky.social · 22/09/2026

Meet @tc3consortium.bsky.social Fellow Lola Zovko! Lola is a PhD candidate in the Department of Pharmacology and Toxicology at the @utoronto.ca, supervised by Dr. Ali Salahpour. Her doctoral work focuses on the effects of endocannabinoid modulation in an acute mouse model of Parkinson's disease.

121

Toronto Cannabis and Cannabinoid Research Consortium @tc3consortium.bsky.social · 03/09/2026

Through randomized controlled studies, these projects examine how THC potency and dose influence acute impairment, with the goal of informing road safety and public health guidance. #cannabis #roadsafety #driving #publichealth #edibles #PhDLife #AcademicCommunity #Research

000

Toronto Cannabis and Cannabinoid Research Consortium @tc3consortium.bsky.social · 03/09/2026

His doctoral research focuses on the effects of varying doses of smoked and edible cannabis on simulated driving performance, cognition, and subjective mood experiences.

100

Toronto Cannabis and Cannabinoid Research Consortium @tc3consortium.bsky.social · 03/09/2026

Meet @tc3consortium.bsky.social Fellow Adam Zaweel, Pharm.D.! Adam is a PhD candidate in the Department of Pharmacology and Toxicology at the @utoronto.ca, co-supervised by Dr. Bernard Le Foll and Dr. Christine Wickens at the Centre for Addiction and Mental Health (@camhnews.bsky.social ).

110

Toronto Cannabis and Cannabinoid Research Consortium @tc3consortium.bsky.social · 31/08/2026

... for the treatment of substance use disorders, including alcohol use disorder, tobacco use disorder, and cannabis use disorder. 3/3

010

Toronto Cannabis and Cannabinoid Research Consortium @tc3consortium.bsky.social · 31/08/2026

She works with Professor Christian Hendershot in the USC Department of Population and Public Health Sciences conducting clinical trials and human laboratory studies focused on incretin-based therapies (e.g., GLP-1 receptor agonists and GLP-1/GIP receptor agonists)... 2/3

110

Toronto Cannabis and Cannabinoid Research Consortium @tc3consortium.bsky.social · 31/08/2026

Congratulations to @tc3consortium.bsky.social Fellow Alumna Maryam Sorkhou on completing her doctoral studies at the @utoronto.ca! Maryam began working as a Postdoctoral Research Associate at the @usc.edu in August 2026. 1/3 #PhDLife #AcademicCommunity #Congratulations

120

Toronto Cannabis and Cannabinoid Research Consortium @tc3consortium.bsky.social · 27/08/2026

Their findings suggest that Ontario's legal cannabis market is trending toward lower-cost, higher-potency products, a pattern that may have implications for consumer purchasing behavior and public health outcomes. #cannabis #ontario #onpoli #THC #drugpolicy #publichealth

011

Toronto Cannabis and Cannabinoid Research Consortium @tc3consortium.bsky.social · 27/08/2026

👉 THC potency of cannabis products has 📈 since 2022 👉Prices for most flower products, disposable vapes, thread cartridges, and soft chews have significantly 📉 👉Edible products, particularly gummies, and disposable vapes 📈 in market share 👉The total number of products available on the legal market 📉

110

Toronto Cannabis and Cannabinoid Research Consortium @tc3consortium.bsky.social · 27/08/2026

The team analyzed 1,727 products listed on the Ontario Cannabis Store, the province's sole legal wholesaler, and compared findings to their previous 2022 dataset. Here is what they found:

110

Toronto Cannabis and Cannabinoid Research Consortium @tc3consortium.bsky.social · 27/08/2026

on a study to investigate trends in cannabis products, potency, and pricing in Ontario's legal recreational market, five years after federal legalization.

110

Toronto Cannabis and Cannabinoid Research Consortium @tc3consortium.bsky.social · 10/08/2026

This systematic review examined the impact of repetitive transcranial magnetic stimulation (rTMS) on sleep in individuals with substance use disorders.

000

Toronto Cannabis and Cannabinoid Research Consortium @tc3consortium.bsky.social · 04/08/2026

Dr. Matheson hopes to soon start their own lab to explore how biological and sociocultural factors converge to impact substance use health and to build towards development of sex- and gender-informed treatments for SUDs. #cannabis #THC #cannabinoid #research #driving #sex #gender #SUD #Treatment

041

Toronto Cannabis and Cannabinoid Research Consortium @tc3consortium.bsky.social · 04/08/2026

Their own research program focuses on understanding how sex, gender, and intersecting social factors influence cannabis use and substance use health, with the goal of improving prevention and treatment of substance use disorders (SUDs). @camhnews.bsky.social

131

Toronto Cannabis and Cannabinoid Research Consortium @tc3consortium.bsky.social · 04/08/2026

Meet @tc3consortium.bsky.social Fellow Alum Dr. Justin Matheson @justinrmatheson.com! Dr. Justin Matheson is currently the Research Manager of the Driving Simulator Laboratory at the Centre for Addiction and Mental Health, where they support a range of projects related to cannabis and impairment.

131

Toronto Cannabis and Cannabinoid Research Consortium @tc3consortium.bsky.social · 23/07/2026

The lessons learned, interesting data, and insightful discussions and perspectives from that intensive day are still with us. A huge thank you to our lead organizers, Justin Matheson, Catharine Mielnik, & Christina Pereira, and engaged participants. @justinrmatheson.com @camielnik.bsky.social

110

Toronto Cannabis and Cannabinoid Research Consortium @tc3consortium.bsky.social · 23/07/2026

Reflecting back on the incredible energy from our 2nd Annual Workshop on Equity Diversity Inclusion and Accessibility in #cannabis and #cannabinoid #research at the @utoronto.ca earlier this summer.

130

Toronto Cannabis and Cannabinoid Research Consortium @tc3consortium.bsky.social · 22/07/2026

These results indicate that the endocannabinoid system may be a promising target not only for the treatment of AD, but also for its diagnosis. This work adds to the growing body of evidence underscoring the need to consider sex differences in diagnostics and drug development.

100

Toronto Cannabis and Cannabinoid Research Consortium @tc3consortium.bsky.social · 22/07/2026

Their findings show that both the CB1 #cannabinoid receptor and the endocannabinoid-degrading enzyme, MAG lipase are altered in an age-, sex- and pathology-specific manner, beginning in the early stages of beta amyloid pathology.

110

Toronto Cannabis and Cannabinoid Research Consortium @tc3consortium.bsky.social · 20/07/2026

and larger randomized trials to replicate these findings and clarify the mechanisms linking abstinence to symptom changes in patients with comorbid PTSD and CUD. #cannabis #PTSD #recovery #CUD #psychiatry #clinicaltrial #patienteducation

001

Toronto Cannabis and Cannabinoid Research Consortium @tc3consortium.bsky.social · 20/07/2026

Recommendations stemming from this study include routine assessment of cannabis use throughout PTSD treatment, patient education on the potential consequences of continued use ++

100

Toronto Cannabis and Cannabinoid Research Consortium @tc3consortium.bsky.social · 20/07/2026

The team found that sustained cannabis abstinence over 12 weeks was associated with reduced PTSD symptom severity and frequency. These findings challenge the assumption that long-term cannabis use improves symptoms or functioning in individuals with PTSD. Instead, it could limit recovery.

100

Toronto Cannabis and Cannabinoid Research Consortium @tc3consortium.bsky.social · 20/07/2026

@tc3consortium.bsky.social fellows, Justyne Rodas (alum) & Maryam Sorkhou, & Members, Drs. Tony George, Stefan Kloiber & Ahmed Hassan, collaborated on a preliminary open-label study to assess impact of cannabis abstinence on symptoms of PTSD in people with comorbid PTSD & CUD. tinyurl.com/yc2d4ebd

tinyurl.com

The Effects of Extended Cannabis Abstinence in Comorbid Posttraumatic Stress Disorder and Cannabis Use Disorder

Participants who achieved abstinence reported significantly greater reductions in total PTSD symptom severity and symptom count compared to those who did not.

110

Toronto Cannabis and Cannabinoid Research Consortium @tc3consortium.bsky.social · 16/07/2026

No significant effects were observed on other neuropsychiatric symptoms although additional research is required.

000

Toronto Cannabis and Cannabinoid Research Consortium @tc3consortium.bsky.social · 16/07/2026

Overall, #cannabinoids may help reduce #agitation in people living with severe #dementia and efficacy was significant at doses of at least 10 mg THC. Cannabinoids were well-tolerated overall, albeit with sedative effects more commonly reported in the cannabinoid group.

100

Toronto Cannabis and Cannabinoid Research Consortium @tc3consortium.bsky.social · 16/07/2026

No significant effects were observed on neuropsychiatric symptoms although additional research is required.

000

Toronto Cannabis and Cannabinoid Research Consortium @tc3consortium.bsky.social · 16/07/2026

100

Reposted by Toronto Cannabis and Cannabinoid Research Consortium

Justin Matheson, PhD (he/they) @justinrmatheson.com · 26/06/2026

Heading off to France for #ICRS2026 Re-sharing the cannabis starter pack I made since I haven't updated this in a long time - let me know if you want to be added!

052

Toronto Cannabis and Cannabinoid Research Consortium @tc3consortium.bsky.social · 14/07/2026

The findings reinforce the importance of public health education and research especially as high potency cannabis is increasingly available. #cannabis #driving #roadsafety #impaireddriving #THC #smoking #publichealth

020

Toronto Cannabis and Cannabinoid Research Consortium @tc3consortium.bsky.social · 14/07/2026

The study investigated the impact of Δ9-THC potency in smoked cannabis on driving performance and showed that higher potency cannabis was associated with greater driving impairment, uncovering potency-dependent impairments in simulated driving exercises.

120

Toronto Cannabis and Cannabinoid Research Consortium @tc3consortium.bsky.social · 13/07/2026

We wish Mikayla success in her long term goal of pursuing a MA/PhD in Clinical Psychology!

010

Toronto Cannabis and Cannabinoid Research Consortium @tc3consortium.bsky.social · 13/07/2026

She is also a clinical research assistant in the Cognitive Brain Health Lab at Sunnybrook Health Sciences Centre where she is supporting studies related to menopause and women’s brain health.

110

Toronto Cannabis and Cannabinoid Research Consortium @tc3consortium.bsky.social · 13/07/2026

She is currently a research assistant in the Trauma Informed Responses Research Group at OISE where she supports several projects focusing on the experiences of survivors of intimate partner violence.

110

Toronto Cannabis and Cannabinoid Research Consortium @tc3consortium.bsky.social · 13/07/2026

Congratulations to @tc3consortium.bsky.social Trainee Alumna Mikayla Lisi 🙌🎉 Mikayla recently graduated with a Master of Education in Developmental Psychology from the Ontario Institute for Studies in Education at UofT @utoronto.ca #AcademicCommunity #AcademicLife #PhDLife #Research

120

Toronto Cannabis and Cannabinoid Research Consortium @tc3consortium.bsky.social · 13/07/2026

000

Toronto Cannabis and Cannabinoid Research Consortium @tc3consortium.bsky.social · 03/07/2026

She hopes that her research will enhance our understanding of the endocannabinoid system in SAD and support the research of future endocannabinoid-targeting treatments.

020

Toronto Cannabis and Cannabinoid Research Consortium @tc3consortium.bsky.social · 03/07/2026

Christina's research focuses on using neuroimaging to investigate the endocannabinoid enzyme, fatty acid amid hydrolase, in individuals with social anxiety disorder (SAD) and how it may be involved in social stress response.

130

Toronto Cannabis and Cannabinoid Research Consortium @tc3consortium.bsky.social · 03/07/2026

Meet @tc3consortium.bsky.social Fellow Christina Pereira! Christina is a PhD. candidate at the Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto under the supervision of Dr. Isabelle Boileau and Dr. Stefan Kloiber. #endocannabinoid #socialanxiety #stress

141

Toronto Cannabis and Cannabinoid Research Consortium @tc3consortium.bsky.social · 29/05/2026

Dr. Victor Tang, Dr. James MacKillop, Dr. Iris Balodis and Dr. Karim Ladha. #cannabis #canada #research

000

Toronto Cannabis and Cannabinoid Research Consortium @tc3consortium.bsky.social · 29/05/2026

TC3 is kicking off day 3 of the 2026 Canadian Cannabis Research Summit co-hosted with @ccicbluesky.bsky.social @utoronto.ca with a electric panel on the "Opportunities and Challenges for Cannabis Researchers in Canada" Panelists included CIHR-INHMA Scientific Director, Prof. Patricia Conrod,

100

Toronto Cannabis and Cannabinoid Research Consortium @tc3consortium.bsky.social · 29/05/2026

We are excited to have you at this year's Canadian Cannabis Research Summit, Dr. Hurd @neurovoice.bsky.social ! Looking forward to your talk this afternoon. @ccicbluesky.bsky.social

011